Advanced Search
About
About GRU
Content Partners
Meetings
Future Directions in Urology Symposium
Perspectives in Urology: Point-Counterpoint
International Prostate Cancer Update
International Bladder Cancer Update
Southwest Prostate Cancer Symposium™
Topics
Faculty
Featured Content
Publication
Join GRU
Select Page
Featured Content
Enhance your practice by watching the Platinum Lectures Series, To the Point, Around the World featuring
Grand Rounds in Urology
expert faculty
View
Meetings & Conferences
Learn more about our organized multi-specialty conferences and symposia that feature leading experts in the field of urology and genitourinary cancers.
Our Meetings
Expert Faculty
Leading Experts in Urology Are Our Faculty, led by
Medical Editor, E. David Crawford, MD
Our Faculty
Join Our Community
Join Our Community Today to Watch, Listen, Learn, and Engage Others i
n the Urology Community
Join GRU
Featured Content
View All
Platinum Lecture Series
The Pros and Cons of Evaluating Hematuria
Matthew E. Nielsen, MD, MS
Need to Know
The Evolving Treatment of Upper Tract Urothelial Carcinoma (UTUC)
Seth P. Lerner, MD
Need to Know
AR-V7 in Castration Resistant Prostate Cancer
Emmanuel Antonarakis, MD
Need to Know
Prostate Brachytherapy
Brian J. Moran, MD
Need to Know
An Update on the PROSPER Trial: Focusing on Nonmetastatic CRPC
Maha H. Hussain, MD, FACP, FASCO
Need to Know
Molecular Diagnostic of Prostate Cancer Based on Non Invasive Liquid Biopsies
Jack A. Schalken, PhD
Need to Know
Radiogland Therapy Optimization of PSMA-Targeted Radiation
Scott T. Tagawa, MD
Need to Know
ERA 223 Study | Concerns About Using Radium-223 and Abiraterone
E. David Crawford, MD
Platinum Lecture Series
Urinary Molecular Marker Tests in Bladder Cancer: An Overview of Cxbladder
Sia Daneshmand, MD
To the Point
Theranostics in Prostate Cancer
Phillip J. Koo, MD
Ask the Expert
Q&A Ask the Expert | Re-Evaluating Patients with Gleason 8
Francisco G. La Rosa, MD, FACS
Need to Know
Hereditary Prostate Cancer
Alexandria Meyer
Latest Content
View All
Negotiating Hospital Contracts
Evan R. Goldfischer, MD, MBA, FACS
Advanced Disease — A Real Need for Understanding and Shared Care
Daniel P. Petrylak, MD
Bone Metastases and Mortality — Can We Be Doing More?
Leonard G. Gomella, MD, FACS
A Value-Based Health Care Model and PCa
Scott B. Sellinger, MD
Update on Radiopharmaceuticals— Choosing a Companion Drug to Radium-223
Phillip J. Koo, MD
The Role of Molecular Imaging in Managing High Risk and Recurrent Prostate Cancer
Robert E. Reiter, MD, MBA
The Evolving Treatment of Upper Tract Urothelial Carcinoma (UTUC)
Seth P. Lerner, MD
Immunotherapy 101 for the Urologist
Raoul S. Concepcion, MD, FACS
The Role of Targeting DNA Repair with PARP
L. Michael Glodé, MD, FACP
Timing of ADT and Chemotherapy
Thomas E. Keane, MD
New Considerations for Oligometastatic Prostate Cancer
Thomas J. Pugh, MD
Point Counterpoint in ADT—Agonists versus Antagonists
Lawrence Karsh, MD, FACS
Meetings
View All
International Prostate Cancer Update
Grand Rounds
International Bladder Cancer Update
Grand Rounds
Southwest Prostate Cancer Symposium™
Grand Rounds
Future Directions in Urology Symposium (FDUS)
Grand Rounds
Perspectives in Urology: Point-Counterpoint
Grand Rounds
Downloadable Content
View All
ADT Impact on Cardiovascular Health
Jehonathan H. Pinthus, MD, PhD, FRCSC
Prostate Cancer: A Review of Current Prostate Cancer Markers and a Novel Model of Organization
E. David Crawford, MD
Other Side Effects: Perception vs. Evidence
Neal D. Shore, MD, FACS
Bones, Hot Flashes, and ADT Use With Chemotherapy and Timing
Thomas E. Keane, MD
Current ADT Challenges
E. David Crawford, MD
Current and Future Approaches to Androgen Deprivation Therapies: Focus of Antiandrogens
E. David Crawford, MD
Biomarkers in Genitourinary Cancers
E. David Crawford, MD
Join the GRU Community
– Why Join? –
Join
You have Successfully Subscribed!
Topics in Urology
Browse our Topics in Urology
Prostate Cancer
Bladder Cancer
Men's Health
Kidney Cancer
